Current role
Sean Mackay
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sean Mackay
The proxy statement of Standard Biotools Inc. reports total compensation of $1,692,543 for Sean Mackay in fiscal 2025, including a base salary of $471,888. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Standard Biotools Inc. (LAB)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Standard Biotools Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Josh Bilenker CEO
- Dr. Michael Egholm CEO
- Michael Egholm CEO, Board Member
- Carlos Paya Chairman
- Tom Carey Chairman, Board Member
- Alex Kim CFO, COO
- Jeffrey G. Black CFO
- Spencer Smith CFO
- Hanjoon Alex Kim COO
- Shane Bowen CTO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Standard Biotools Inc. (LAB) | Chief Business Officer | $471,888 | $1,692,543 |
| 2024 | Standard Biotools Inc. (LAB) | Chief Business Officer | $293,576 | $3,177,155 |
| 2023 | Standard Biotools Inc. (LAB) | Chief Business Officer | — | — |
| 2022 | Standard Biotools Inc. (LAB) | Chief Business Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.